Literature DB >> 16894062

Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study.

Mark Olfson1, Steven C Marcus, David Shaffer.   

Abstract

CONTEXT: The Food and Drug Administration has issued a boxed warning concerning increased suicidal ideation and behavior associated with antidepressant drug treatment in children and adolescents. It is unknown whether antidepressant agents increase the risk of suicide death in children or adults.
OBJECTIVE: To estimate the relative risk of suicide attempt and suicide death in severely depressed children and adults treated with antidepressant drugs vs those not treated with antidepressant drugs.
DESIGN: Matched case-control study.
SETTING: Outpatient treatment settings in the United States. PARTICIPANTS: Medicaid beneficiaries from all 50 states who received inpatient treatment for depression, excluding patients treated for pregnancy, bipolar disorder, schizophrenia or other psychoses, mental retardation, dementia, or delirium. Controls were matched to cases for age, sex, race or ethnicity, state of residence, substance use disorder, recent suicide attempt, number of days since hospital discharge, and recent treatment with antipsychotic, anxiolytic/hypnotic, mood stabilizer, and stimulant medications. MAIN OUTCOME MEASURES: Suicide attempts and suicide deaths.
RESULTS: In adults (aged 19-64 years), antidepressant drug treatment was not significantly associated with suicide attempts (odds ratio [OR], 1.10; 95% confidence interval [CI], 0.86-1.39 [521 cases and 2394 controls]) or suicide deaths (OR, 0.90; 95% CI, 0.52-1.55 [86 cases and 396 controls]). However, in children and adolescents (aged 6-18 years), antidepressant drug treatment was significantly associated with suicide attempts (OR, 1.52; 95% CI, 1.12-2.07 [263 cases and 1241 controls]) and suicide deaths (OR, 15.62; 95% CI, 1.65-infinity [8 cases and 39 controls]).
CONCLUSIONS: In these high-risk patients, antidepressant drug treatment does not seem to be related to suicide attempts and death in adults but might be related in children and adolescents. These findings support careful clinical monitoring during antidepressant drug treatment of severely depressed young people.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16894062     DOI: 10.1001/archpsyc.63.8.865

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  50 in total

1.  DATE: Depressed adolescents treated with exercise: Study rationale and design for a pilot study.

Authors:  Carroll W Hughes; Madhukar H Trivedi; Joseph Cleaver; Tracy L Greer; Graham J Emslie; Beth Kennard; Shauna Dorman; Tyson Bain; Judy Dubreuil; Conrad Barnes
Journal:  Ment Health Phys Act       Date:  2009-12

Review 2.  Strategies for quantifying the relationship between medications and suicidal behaviour: what has been learned?

Authors:  Robert D Gibbons; J John Mann
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

3.  Antidepressant agents and suicide death among US Department of Veterans Affairs patients in depression treatment.

Authors:  Marcia Valenstein; Hyungjin Myra Kim; Dara Ganoczy; Daniel Eisenberg; Paul N Pfeiffer; Karen Downing; Katherine Hoggatt; Mark Ilgen; Karen L Austin; Kara Zivin; Frederic C Blow; John F McCarthy
Journal:  J Clin Psychopharmacol       Date:  2012-06       Impact factor: 3.153

4.  Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study.

Authors:  Douglas G Kondo; Young-Hoon Sung; Tracy L Hellem; Kristen K Fiedler; Xianfeng Shi; Eun-Kee Jeong; Perry F Renshaw
Journal:  J Affect Disord       Date:  2011-08-09       Impact factor: 4.839

Review 5.  Pharmacogenomics of suicidal events.

Authors:  David Brent; Nadine Melhem; Gustavo Turecki
Journal:  Pharmacogenomics       Date:  2010-06       Impact factor: 2.533

Review 6.  Risk of adverse behavioral effects with pediatric use of antidepressants.

Authors:  Wayne K Goodman; Tanya K Murphy; Eric A Storch
Journal:  Psychopharmacology (Berl)       Date:  2006-12-19       Impact factor: 4.530

7.  Studying prescription drug use and outcomes with medicaid claims data: strengths, limitations, and strategies.

Authors:  Stephen Crystal; Ayse Akincigil; Scott Bilder; James T Walkup
Journal:  Med Care       Date:  2007-10       Impact factor: 2.983

8.  Pediatric psychopharmacology: mood, anxiety and disruptive behavior/pervasive developmental disorders.

Authors:  Christopher J McDougle; John H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2007-03       Impact factor: 4.530

Review 9.  Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement.

Authors:  Hans-Jürgen Möller; David S Baldwin; Guy Goodwin; Siegfried Kasper; Ahmed Okasha; Dan J Stein; Rajiv Tandon; Marcio Versiani
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-08       Impact factor: 5.270

10.  Outside the Black Box: Re-assessing Pediatric Antidepressant Prescription.

Authors:  Jacqueline A Sparks; Barry L Duncan
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2013-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.